Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

27 July 2017 : Review article  

Concomitant Thyroid Disease in Patients with Primary Hyperparathyroidism

Linxi ZhangABCDEF, Deepak BalaniABDEF, Yiming MuABDEF

DOI: 10.12659/MSRev.905460

Med Sci Rev 2017; 4:7-12


Primary hyperparathyroidism (pHPT) is often accompanied by thyroid diseases, which may be confusing in understanding preoperative parathyroid disease conditions and thereby complicate the intraoperative decision-making process. In this review, we aimed to provide an updated overview of the coincidence of these disorders. We conducted a PubMed search for articles using the following key words: primary hyperparathyroidism, thyroid disease, nodular hyperplasia, papillary carcinoma, Graves’ disease, and thyroiditis. Articles were obtained and reviewed to analyze the coexistence of primary hyperparathyroidism and thyroid diseases. The findings of coexisting thyroid disease in patients with primary hyperparathyroidism were reported in the range of 22% to 70%, including nodular hyperplasia, papillary carcinoma, Hashimoto’s thyroiditis, Hurtle’s adenoma, medullary carcinoma, and Graves’ disease. Several hypotheses have been presented to understand mechanisms that link thyroid disease to pHPT, but no firm conclusions currently exist regarding the etiologic relationship between these 2 disorders. Ultrasonography (US) and 99m-Technetium-Methoxy-isobutylisonitril (99mTc-MIBI) scintigraphy are essential in the evaluation of these patients, which can be helpful to modify the planned procedure. A definitive one-step surgery to treat both pathologies allows patients to avoid the risks associated with re-operative neck surgery and associated morbidity. Attention should be paid to the possible coincidence of thyroid and parathyroid diseases, thus leading to safer and more efficient management of these patients.

Keywords: Carcinoma, Papillary, Focal nodular hyperplasia, Hyperparathyroidism, Primary, Thyroid Diseases

Add Comment 0 Comments


01 September 2023 : Editorial  

Editorial: A Rapid Global Increase in COVID-19 is Due to the Emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.942244

Med Sci Monit 2023; 29:e942244


In Press

28 Sep 2023 : Clinical Research  

Trends in Hospitalization Duration for Rare Diseases: A Retrospective Analysis of Sarcoidosis, Still's Dise...

Med Sci Monit In Press; DOI: 10.12659/MSM.941536  

27 Sep 2023 : Laboratory Research  

Enhanced Proliferation and Adhesion Marker Gene Expression in Fibroblast Cells: Evaluating the Efficacy of ...

Med Sci Monit In Press; DOI: 10.12659/MSM.941641  

26 Sep 2023 : Clinical Research  

Hypothalamic Injury and Clinical Outcomes in Patients with Post-Traumatic Hyponatremia: A Diffusion Tensor ...

Med Sci Monit In Press; DOI: 10.12659/MSM.942397  

26 Sep 2023 : Clinical Research  

Psychometric Properties of the Polish Version of the FACIT-Sp-12: Assessing Spiritual Well-Being Among Pati...

Med Sci Monit In Press; DOI: 10.12659/MSM.941769  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788


30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750